Answers are grounded in this paper and cite their sources.
Background Congenital heart disease (CHD) is a leading cause of neonatal morbidity and mortality, necessitating early detection for improved outcomes. Current screening methods, such as pulse oximetry and cardiac auscultation, have limitations when used independently. Objectives This study aimed to evaluate the diagnostic accuracy of combining pulse oximetry and cardiac auscultation for early CHD detection in neonates, particularly in resource-limited settings. Methods A prospective cross-sectional study was conducted from October 2021 to October 2022 at a University Hospital. A total of 12,708 neonates were screened using pulse oximetry and cardiac auscultation within 6–72 hours post-birth. Echocardiography served as the gold standard for confirmation. Sensitivity, specificity, and overall diagnostic accuracy were assessed for each screening method individually and in combination. Results CHD was detected in 344 neonates (3%). Cardiac auscultation was more effective in identifying acyanotic CHDs (e.g., ventricular septal defect and atrial septal defect), while pulse oximetry was superior in detecting cyanotic CHDs (e.g., transposition of the great arteries). The combined approach achieved a diagnostic accuracy of 95.5%, with 96.7% sensitivity and 92% specificity, outperforming either method alone. Conclusion Combining pulse oximetry and cardiac auscultation significantly enhances CHD screening accuracy, ensuring early diagnosis and intervention. This cost-effective approach is particularly valuable in low-resource settings, improving neonatal outcomes and reducing CHD-related mortality. These findings support the universal adoption of dual-method screening in neonatal care.
No takes yet. Share an insight, caveat, or question.
Mahmoud et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: